The The Effect of Epigallocatechin 3-gallate on Body Weight and Abdominal Fat of white rats (Rattus norvegicus) exposed to Monosodium glutamate
DOI:
https://doi.org/10.5380/avs.v29i4.95789Keywords:
cardiovascular disease, epididymal, obesity, peritoneal, retroperitonealAbstract
Abstract: MSG can caused obesity that can affect metabolism in the body. The administration of EGCG can increase energy expenditure and metabolism. This study aimed to determine the effect of epigallocatechin 3-gallate (EGCG) on body weight and the percentage of abdominal fat of white rats (Rattus norvegicus) exposed to monosodium glutamate (MSG). Twenty-five rats were divided into five treatment groups. The C- group was given only aquadest and Sodium carboxymethyl cellulose (CMC-Na) 1%. The C+, T1, T2, and T3 groups were given MSG 120 mg/kg/BW and CMC-Na 1%, and EGCG at 4, 8, and 16 mg/kg/BW, respectively. All treatments were given orally for 28 days. The results showed that administration of MSG tends to be followed by an increase in body weight, except in group T2 where body weight was relatively stable. The administration of MSG 120 (to the C+ group) increased significantly (p<0.05) the percentage of epididymal fat and peritoneal fat. The administration of EGCG 8 (to the T2 group) significantly reduced (p<0.05) the percentage of retroperitoneal, epididymal, and peritoneal fat, compared to the group exposed to (C+ group). The percentage of retroperitoneal fat and epididymal fat was significantly lower (p<0.05), but the percentage of peritoneal fat was not significantly different (p>0.05) compared to normal mice (C-). The administration of EGCG 16 (to the T3 group) followed a significant increase (p<0.05) in retroperitoneal fat and epididymal fat, but the percentage of peritoneal fat was not significantly different (p>0.05), compared to (T2 group). It could be concluded that the administration of EGCG 8 mg/kg BW/day reduced the weight of retroperitoneal fat, epididymal fat, and peritoneal fat compared to mice given MSG alone. This research is expected to become the main reference for product processed from the substance EGCG which can reduce body weight and abdominal fat.
Keywords: cardiovascular disease, epididymal, obesity, peritoneal, retroperitoneal.
References
Bautista R.J.H., Mahmoud, A.M., Königsberg, M., Guerrero, N.E.L.D. (2019). Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants. Biomedicine & Pharmacotherapy, 111, 503-516. https://doi.org/10.1016/j.biopha.2018.12.108.
Bayram, H. M., Akgoz, H. F., Kizildemir, O. and Ozturkcan, A. (2022). Monosodium glutamate: review on preclinical and clinical reports. Biointerface Res. Appl. Chem. 13(2), 1 - 27. https://doi.org/10.33263/BRIAC132.149
Chatree, S., Sitticharoon, C., Maikaew, P., Pongwattanapakin, K., Keadkraichaiwat, I., Churintaraphan, M., Sripong, C., Sririwichitchai, R., & Tapechum, S. (2021). Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects. Experimental biology and medicine (Maywood, N.J.), 246(2), 163–176. https://doi.org/10.1177/1535370220962708
Chen, I. J., Liu, C. Y., Chiu, J. P., & Hsu, C. H. (2016). Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clinical nutrition (Edinburgh, Scotland), 35(3), 592–599. https://doi.org/10.1016/j.clnu.2015.05.003
Choi, C., Song, H. D., Son, Y., Cho, Y. K., Ahn, S. Y., Jung, Y. S., Yoon, Y. C., Kwon, S. W., & Lee, Y. H. (2020). Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues. Nutrients, 12(10), 3072. https://doi.org/10.3390/nu12103072
Chusyd, D. E., Wang, D., Huffman, D. M., & Nagy, T. R. (2016). Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots. Frontiers in nutrition, 3, 10. https://doi.org/10.3389/fnut.2016.00010
Cohn, J. S., Kamili, A., Wat, E., Chung, R. W., & Tandy, S. (2010). Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atherosclerosis. Supplements, 11(1), 45–48. https://doi.org/10.1016/j.atherosclerosissup.2010.04.004
Elffers, T. W., de Mutsert, R., Lamb, H. J., de Roos, A., Willems van Dijk, K., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2017). Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PloS one, 12(9), e0185403. https://doi.org/10.1371/journal.pone.0185403
Jubaidi, F. F., Mathialagan, R. D., Noor, M. M., Taib, I.S. and Budin, S. B. (2019). Monosodium glutamate daily oral supplementation: study of its effects on male reproductive system on rat model. Journal of System Biology in Reproductive Medicine. 65(3), 194-204. https://doi.org/10.1080/19396368.2019.1573274
Kayode, O. T., Bello, J. A., Oguntola, J. A., Kayode, A. A. A., & Olukoya, D. K. (2023). The interplay between monosodium glutamate (MSG) consumption and metabolic disorders. Heliyon, 9(9), e19675. https://doi.org/10.1016/j.heliyon.2023.e19675
Khutami, C., Sumiwi, S. A., Khairul Ikram, N. K., & Muchtaridi, M. (2022). The Effects of Antioxidants from Natural Products on Obesity, Dyslipidemia, Diabetes and Their Molecular Signaling Mechanism. International journal of molecular sciences, 23(4), 2056. https://doi.org/10.3390/ijms23042056
Kim, H. S., Quon, M. J., & Kim, J. A. (2014). New insights into the mechanisms of polyphenols beyond antioxidant properties, lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox biology, 2, 187–195. https://doi.org/10.1016/j.redox.2013.12.022
Kurogi, M., Kawai, Y., Nagatomo, K., Tateyama, M., Kubo, Y., & Saitoh, O. (2015). Auto-oxidation products of epigallocatechin gallate activate TRPA1 and TRPV1 in sensory neurons. Chemical senses, 40(1), 27–46. https://doi.org/10.1093/chemse/bju057
Kurtanty, D., Faqih, D. M., & Upa, N. P. (2019). Review Monosodium Glutamat How to Understand it Properly. Journal of Chemical Information and Modeling. 53(9), 7-15. https://doi.org/10.1017/CBO9781107415324.004
Li, F., Gao, C., Yan, P., Zhang, M., Wang, Y., Hu, Y., Wu, X., Wang, X., & Sheng, J. (2018). EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice. Frontiers in pharmacology, 9, 1366. https://doi.org/10.3389/fphar.2018.01366
Li, W., Zhu, C., Liu, T., Zhang, W., Liu, X., Li, P., & Zhu, T. (2020). Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats. Diabetes & vascular disease research, 17(6), 1479164120966998. https://doi.org/10.1177/1479164120966998
Luo, S., Gill, H., Dias, D. A., Li, M., Hung, A., Nguyen, L. T., & Lenon, G. B. (2019). The inhibitory effects of an eight-herb formula (RCM-107) on pancreatic lipase: enzymatic, HPTLC profiling and in silico approaches. Heliyon, 5(9), e02453. https://doi.org/10.1016/j.heliyon.2019.e02453
Macêdo, A.P.A., Gonçalves, M.d.S., Barreto-Medeiros, J.M., da Silva Neto, O.C., David, J.M., Villarreal, C.F., Macambira, S.G., Pereira Soares, M.B., Couto, R.D. (2023). Green Tea Induces the Browning of Adipose Tissue—Systematic Review. Obesities, 3, 193-206. https://doi.org/10.3390/obesities3030016
Mawarti, H., Ratnawati, R. dan Lyrawati, D. (2012). Epigallocatechin Gallate Menghambat Resistensi Insulin pada Tikus dengan Diet Tinggi Lemak. Jurnal Kedokteran Brawijaya, 27(1), 43-50. https://doi.org/10.21776/ub.jkb.2012.027.01.8
Miranda, R. A., Agostinho, A. R., Trevenzoli, I. H., Barella, L. F., Franco, C. C., Trombini, A. B., Malta, A., Gravena, C., Torrezan, R., Mathias, P. C. F. and de Oliveira, J. C. (2014). Insulin oversecretion in MSG-obese rats is related to alterations in cholinergic muscarinic receptor subtypes in pancreatic islets. Cell Physiol Biochem, 33(4), 1075 - 1086. https://doi.org/10.1159/000358677
Nauli, A. M., & Matin, S. (2019). Why Do Men Accumulate Abdominal Visceral Fat?. Frontiers in physiology, 10, 1486. https://doi.org/10.3389/fphys.2019.01486
Niaz, K., Zaplatic, E., & Spoor, J. (2018). Extensive use of monosodium glutamate: A threat to public health?. EXCLI journal, 17, 273–278. https://doi.org/10.17179/excli2018-1092
Ohishi, T., Fukutomi, R., Shoji, Y., Goto, S., & Isemura, M. (2021). The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee, Wine, and Curry on Obesity. Molecules (Basel, Switzerland), 26(2), 453. https://doi.org/10.3390/molecules26020453
Panuganti, K. K., Nguyen, M., & Kshirsagar, R. K. (2023). Obesity. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29083734/
Rene, J. H. B., Ayman, M. M., Mina, K. and Norma, E. L. D. G. (2019). Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants. Journal of Biomedicine and Pharmacotherapy, 111, 503 - 516. https://doi.org/10.1016/j.biopha.2018.12.108
Rudyk, M., Hurmach, Y., Serhiichuk, T., Akulenko, I., Skivka, L., Berehova, T., & Ostapchenko, L. (2023). Multi-probiotic consumption sex-dependently interferes with MSG-induced obesity and concomitant phagocyte pro-inflammatory polarization in rats: Food for thought about personalized nutrition. Heliyon, 9(2), e13381. https://doi.org/10.1016/j.heliyon.2023.e13381
Saito, M., Matsushita, M., Yoneshiro, T., & Okamatsu-Ogura, Y. (2020). Brown Adipose Tissue, Diet-Induced Thermogenesis, and Thermogenic Food Ingredients: From Mice to Men. Frontiers in endocrinology, 11, 222. https://doi.org/10.3389/fendo.2020.00222
Santana, A., Santamarina, A., Souza, G., Mennitti, L., Okuda, M., Venancio, D., Seelander, M., do Nascimento, C. O., Ribeiro, E., Lira, F. and Oyama, L. (2015). Decaffeinated green tea extract rich in epigallocatechin 3-gallate improves insulin resistance and metabolic profiles in normolipidic diet-but not high-fat diet-fed mice. The Journal of Nutritional Biochemistry, 9(26), 893 - 902. https://doi.org/10.1016/j.jnutbio.2015.03.001
Tang, G., Xu, Y., Zhang, C., Wang, N., Li, H., & Feng, Y. (2021). Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. Antioxidants (Basel, Switzerland), 10(7), 1076. https://doi.org/10.3390/antiox10071076
Tsuneyama, K., Nishida, T., Baba, H., Taira, S., Fujimoto, M., Nomoto, K. and Imura, J. (2014). Neonatal monosodium glutamate treatment causes obesity, diabetes and macrovesicular steatohepatitis with liver nodules in DIAR mice. J. Gastroenterol Hepatol, 1736 - 1743. https://doi.org/10.1111/jgh.12610
Wang, Y., Xia, H., Yu, J., Sui, J., Pan, D., Wang, S., Liao, W., Yang, L., & Sun, G. (2023). Effects of green tea catechin on the blood pressure and lipids in overweight and obese population-a meta-analysis. Heliyon, 9(11), e21228. https://doi.org/10.1016/j.heliyon.2023.e21228
Xu, H., Zhong, X., Wang, T., Wu, S., Guan, H., & Wang, D. (2023). (-)-Epigallocatechin-3-Gallate Reduces Perfluorodecanoic Acid-Exacerbated Adiposity and Hepatic Lipid Accumulation in High-Fat Diet-Fed Male C57BL/6J Mice. Molecules (Basel, Switzerland), 28(23), 7832. https://doi.org/10.3390/molecules28237832
Yang, C. S., Zhang, J., Zhang, L., Huang, J., & Wang, Y. (2016). Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Molecular nutrition & food research, 60(1), 160–174. https://doi.org/10.1002/mnfr.201500428
Yoshitomi, R., Yamamoto, M., Kumazoe, M., Fujimura, Y., Yonekura, M., Shimamoto, Y., Nakasone, A., Kondo, S., Hattori, H., Haseda, A., Nishihira, J. and Tachibana, H. (2021). The Combined Effect of Green Tea and α-Glucosyl Hesperidin in Preventing Obesity: A Randomized Placebo-Controlled Clinical Trial. Journal of Scientific Reports. 11(1): 1 – 8. https://doi.org/10.1038/s41598-021-98612-6
Zou, Y., Sheng, G., Yu, M., & Xie, G. (2020). The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve. PloS one, 15(11), e0243068. https://doi.org/10.1371/journal.pone.0243068
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Archives of Veterinary Science
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors that wish to publish in AVS agree with the following conditions:
- To keep copyright of the article and allow the AVS to publish the first time. The article will be licensed by Creative Commons - Atribuição 4.0 Internacional allowing the sharing of their work.
- Authors may distribute their work by other channel of distribution (ex.: local or public repository).
- Authors have the permission to publish their work online, using different channels (similar to above), even before the final editorial process.
